Efficacy and Safety of S1P1 Receptor Modulator Drugs for Patients with Moderate-to-Severe Ulcerative Colitis

Ulcerative colitis (UC) is a chronic inflammatory bowel disease (IBD) that negatively impacts patients’ quality of life. In the last decades, the therapeutic options available for the management of patients with moderate to severe UC have increased significantly, including not only biological drugs...

Descripción completa

Detalles Bibliográficos
Autores principales: Bencardino, Sarah, D’Amico, Ferdinando, Faggiani, Ilaria, Bernardi, Francesca, Allocca, Mariangela, Furfaro, Federica, Parigi, Tommaso Lorenzo, Zilli, Alessandra, Fiorino, Gionata, Peyrin-Biroulet, Laurent, Danese, Silvio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10419826/
https://www.ncbi.nlm.nih.gov/pubmed/37568417
http://dx.doi.org/10.3390/jcm12155014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10419826/
https://www.ncbi.nlm.nih.gov/pubmed/37568417
http://dx.doi.org/10.3390/jcm12155014

Ejemplares similares